News

Using AI to identify kidney anatomy issues

Using AI to identify kidney anatomy issues

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis

Research & Data

Using AI to identify kidney anatomy issues

About the research

UNOS researchers explored whether artificial intelligence (AI) can help identify anatomical issues in donor kidneys before transplant. The system analyzes photos taken during kidney procurement to see whether the organs appear normal or have structural issues that could affect transplant success.

Using existing OPTN data, the UNOS team built a dataset where each donor had a set of photos, filtering out low-quality or irrelevant images. Donors were labeled as follows:

  • No anatomical issues = both kidneys were successfully transplanted
  • Anatomical issues = at least one organ was refused due to anatomy concerns

UNOS researchers then trained the AI model to review sets of donor photos and predict whether anatomical issues were present. The subject matter experts did not provide the model with any direct guidance–it learned from the images and outcomes alone.

Key findings

The AI model showed promising performance in identifying anatomical issues.

Performance metrics:

Icon
When the model flagged an issue, it was correct about two-thirds of the time.

  • If the model flagged three cases as having anatomical issues, two of the cases would be true instances of anatomical issues, and one would be a “false alarm.”

Icon
The model accurately identified two-thirds of true anatomical issues

  • The model would accurately catch two out of three anatomical issues, and would miss one true case

Why this matters

Deciding whether a donor kidney is suitable for transplant is a critical step in the transplant process.

This research shows that AI could help support clinical decision-making by automatically detecting anatomy issues and improving the consistency of identification.

Improvements in how organs are evaluated could help ensure more patients receive successful transplants.

What’s next

This work showed promising results, but the model still has room for improvement. Potential future work may include:

  • Improving how the AI model is trained so it becomes more accurate
  • Working with clinicians in the transplant community to better define and label anatomical issues

With further development, tools like this could help improve the pre-transplant organ evaluation process and support better outcomes for patients.

About UNOS research

UNOS conducts research as part of its mission to save and transform lives through research, innovation and collaboration.


The data reported here have been supplied by UNOS as the contractor for the Organ Procurement and Transplantation Network (OPTN). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by the OPTN or the U.S. Government.

This study used data from the Organ Procurement and Transplantation Network (OPTN). The OPTN data system includes data on all donors, wait-listed candidates, and transplant recipients in the US, submitted by the members of the Organ Procurement and Transplantation Network (OPTN). The Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services provides oversight to the activities of the OPTN contractor.

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight

Paul Rocheleau joins UNOS Board of Directors

Paul Rocheleau joins UNOS Board of Directors

Today, the United Network for Organ Sharing (UNOS) announced that Paul Rocheleau has joined its Board of Directors.

Rocheleau has decades of experience leading and operating global corporations, life sciences ventures, research-university initiatives and nonprofit entities, and brings a strategic insight that has helped organizations identify opportunities and grow.

He played a significant role in advancing life sciences and high skilled talent development initiatives in Virginia. As co-founder of Virginia Life Science Investments, LLC, Rocheleau helped attract international startups to the Commonwealth and launch early-stage operations. From 1997 to 2023, he helped establish and grow the College of Engineering at Virginia Commonwealth University, where he served on its foundation and as executive director of strategic programs. While with the university, he created industry partnerships, assisted economic development efforts, and secured public and private funding.

“Paul’s extensive leadership involving life science startups, technology commercialization and global business initiatives will bring a valuable perspective to the UNOS board,” said Mark Johnson, interim CEO of UNOS. “His experience guiding complex organizations through periods of growth and innovation will be highly valued as we enhance the ways we serve the organ donation and transplant system.”

Rocheleau retired in 2023 following a distinguished career. He has held senior executive roles including chief executive officer of Albright & Wilson, a London-based multinational chemical company, and chief financial officer of Albemarle Corp., a global specialty chemicals company. In these roles, he developed and implemented disruptive business strategies, commercialized new technology, created strategic partnerships, and secured funding for acquisitions to support rapid growth.

He has served on the boards of public multinational companies, nonprofit organizations and private companies, including Richmond-based Apex Systems Inc.

“I am honored to join the UNOS board and support its mission to save and improve lives,” Rocheleau said. “I look forward to contributing to the organization’s critically important work as it expands and engages partners across a very complex ecosystem that defines the organ donation and transplant community.”

Rocheleau will begin his term on June 1, 2026, serving until September 30, 2029. He was unanimously approved by a full board vote on May 18, 2026.

Notice of Privacy Practices and UNOS Privacy Policies updated

Notice of Privacy Practices and UNOS Privacy Policies updated

UNOS is committed to protecting the privacy and confidentiality of the individuals we serve. As part of our ongoing efforts to maintain transparency and ensure compliance with evolving regulatory and operational standards, we have recently revised and updated our Notice of Privacy Practices (NPP) as well as the United Network for Organ Sharing (UNOS) Privacy Policies.

These updates reflect enhancements to how personal and health information is collected, used, shared, and safeguarded within our organization and in coordination with national transplant systems. The revisions also align with current legal requirements and best practices in data protection.

What this means

While our core commitment to privacy remains unchanged, the updated policies provide:

  • Greater clarity on how your information may be used and disclosed
  • Additional details about your privacy rights and choices
  • Updated language reflecting current standards and processes
  • Expanded information regarding data security and protection measures

Review the updated policies

We encourage all patients, donors, families, and visitors to review the revised documents to stay informed about how your information is handled and about your rights regarding that information.

Questions or concerns?

If you have any questions about these updates or how your information is protected, please contact our Privacy Office. We are here to help ensure you feel confident and informed about your privacy. Thank you for your continued trust as we work to uphold the highest standards of privacy and care.

 

 

Transplant Quality Dashboard measures what matters

Transplant Quality Dashboard measures what matters

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis
Research & Data

Transplant Quality Dashboard measures what matters

Using benchmarking data to power smarter staffing

Julie Rodriguez knows firsthand how challenging it can be to staff a transplant quality team. As Transplant Quality and Patient Safety Manager at Intermountain Transplant Services, she kept hearing the same concern echoed by peers across the country: quality teams were structured and used differently from one transplant center to another. “There was a lot of chatter on the transplant listserv regarding how transplant teams are being used [at different centers],” Rodriguez says.

A shared challenge across transplant centers

Without a clear picture of how other transplant programs operated, it was difficult to know whether a program was appropriately staffed, or to advocate for change.

Julie Rodriguez

“If we didn't have that data ... it's hard to have a goal.”

—Julie Rodriguez, transplant quality and patient safety manager, Intermountain Health Transplant Services 

Rodriguez teamed up with colleagues from the Organ Donation and Transplantation Alliance’s Transplant Quality Staffing Collaborative to address this gap. The Collaborative partnered with UNOS to design a survey that captures how transplant quality teams are staffed and how they operate.

Turning survey results into actionable data

UNOS invited all quality teams to complete the Transplant Quality Staffing SurveySM. Participating centers can access the results through a new interactive Transplant Quality DashboardSM, designed to help transplant programs benchmark their staffing models against peers across the country.

Rodriguez says the survey and dashboard have changed how her team evaluates staffing, identifies gaps and talks with leadership about the resources they need to support their program. “It gives you some good tools to go to your leadership and say, ‘We need to grow our quality program based on how the quality teams are being used throughout the nation for transplant centers our size or larger,'” Rodriguez says. “It helps me to have those crucial conversations with leadership.”

Setting goals and tracking progress

Benchmarking data also has helped Intermountain set clearer goals and track progress. Being able to benchmark against other transplant centers is critical, Rodriguez says. “If we didn’t have that data … It’s hard to have a goal.” One of Rodriguez’s favorite features of the dashboard is how easy it is to use the visuals. Charts and graphics can be downloaded and dropped directly into presentations, making it simple to communicate key points. “A picture is worth 1,000 words,” she says. “We can go in and snip this data and then put it into our PowerPoints to be able to drive home a particular point or to explain why we need to change a metric.” Rodriguez credits UNOS Tools for helping Intermountain’s transplant program to grow. “When you know that you’re being benchmarked against programs that you [admire], I think that’s helped us extensively,” she says. “Our kidney program is now fourth in the nation, and our liver program is third. So, we’re doing something right and we’re using the UNOS Tools to be able to help us to create those goals for our team.”

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight

UNOS partners with NASA to study transporting organs by drone

Notice of Privacy Practices and UNOS Privacy Policies updated

Mark Johnson, interim CEO of UNOS, and John Koelling, director of aeronautics research at NASA Langley Research Center, sign a partnership agreement to study drone transport for organs.

Mark Johnson, interim CEO of UNOS, and John Koelling, director of aeronautics research at NASA Langley Research Center, sign a partnership agreement to study drone transport for organs.

The United Network for Organ Sharing (UNOS) today announced a new partnership with the National Aeronautics and Space Administration (NASA) to advance the study of how drone technology could make organ transport safer, faster and more efficient.

The partnership was officially launched today during a signing ceremony at UNOS’ Richmond headquarters, beginning a joint effort to further our understanding of how unmanned, unpressurized aerial vehicle (UAV) flights affect organ viability, and explore how this technology could potentially transform the nation’s transplant logistics network.

This work combines NASA’s expertise in aeronautics and flight testing with UNOS’ deep experience in organ donation and transplantation to reimagine what it means to transport organs for transplant.

“This partnership shows what’s possible when innovation and mission-driven health care come together,” said Mark Johnson, UNOS interim chief executive officer. “By combining NASA’s aeronautics capabilities with UNOS’ transplant expertise, we can explore new approaches that may one day help reduce organ transport time and cost, improve efficiency and ultimately save and transform more lives.”

The first phase of this partnership will focus on developing and testing instrumentation to measure how environmental factors such as temperature, vibration, and altitude affect organs during UAV flights carrying research organs. NASA will also analyze potential flight routes, time savings, and ways drone technologies could be integrated into existing transplant logistics, focusing on a first-mile, last-mile route network.

UAV organ transport has the potential to reduce costs, increase routing flexibility, and cut transport times by avoiding traffic and other scheduling constraints.

“I couldn’t be more pleased to be a part of this,” said John Koelling, director of aeronautics research at NASA Langley Research Center during today’s signing ceremony. “Doing something in my backyard that could change the world—how cool is that? That’s almost as cool as stepping foot on the moon.”

Future phases of the collaboration are expected to explore scalability, longer-range flight testing, and regulatory considerations that could support the safe expansion of medical drone operations. The work will also involve collaboration with additional research partners, federal agencies and academic institutions.

UNOS has long supported innovation across the donation and transplant system beyond its role as a contractor for the Organ Procurement and Transplantation Network (OPTN). This partnership with NASA reflects UNOS’ commitment to exploring innovative solutions that strengthen the system.

Read NASA’s press release

UNOS Predict 2.0 allows transplant centers to make smarter, data-driven decisions

UNOS Predict 2.0 allows transplant centers to make smarter, data-driven decisions

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis

Research & Data

UNOS Predict 2.0 allows transplant centers to make smarter, data-driven decisions

Background

U.S. transplant programs are evaluated by the OPTN on several key metrics developed by the Scientific Registry for Transplant Recipients (SRTR). These metrics include:

  • How often a transplanted organ is still functioning 90 days and one year after transplant
  • Patient deaths while waiting for a transplant per time waiting on the list
  • How often a transplant program accepts an organ offer compared to the number of offers they could have accepted and transplanted
hand holding heart

In 2024, as part of our suite of UNOS Tools, we launched UNOS PredictSM, a tool specifically designed to help transplant programs monitor and forecast how they are performing against these SRTR metrics as data become available. Predict enables transplant programs to identify opportunities to improve patient outcomes.

What’s new in UNOS Predict 2.0

UNOS researchers and data analysts work to develop enhancements to Predict to better support transplants programs. Predict 2.0 launched in early 2026 including:

  • Access to individual patient-level data for post-transplant survival and pre-transplant mortality
  • Offer acceptance ratios for heart and kidney
  • “What if” simulator to explore how different patient scenarios can affect program performance

Why this matters

Shaped by user feedback, these enhancements allow transplant programs to identify trends in their data, prepare for potential challenges, advocate for additional resources, and make informed, data-driven decisions to drive continuous improvement to help save and transform more lives.

Looking ahead

“Predict provides our transplant programs with the essential forward-looking view we need, moving beyond the rearview mirror. It delivers crucial risk-adjusted results, empowering the transplant teams to respond proactively and grow effectively. This allows us to appropriately expand our program’s reach and ultimately, helps us to serve more patients and families.”

— Colleen O’Donnell Flores, MHA, Director of Transplant Quality & Regulatory Affairs, Northwell Health Transplant Institute


UNOS is committed to continuing to improve UNOS Predict, and the team is continuing to review feedback from the community. Feedback and questions can be submitted to [email protected].

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight